Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IN10018 plus chemotherapy in high-grade serous ovarian cancer
CTR20200913Phase 2Completed
- Sponsor
- InnoSience
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ifebemtinib in ovarian cancer, fallopian tube cancer (PFTC), sponsored by InnoSience. Started Jun 2020; status: completed.
02
Drugs
ifebemtinib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)
Beyond the preview
Go deeper on CTR20200913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200913.